These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fibrous dysplasia of bone and McCune-Albright syndrome. Chapurlat RD; Orcel P Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981 [TBL] [Abstract][Full Text] [Related]
8. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome. Kochar IP; Kulkarni KP Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120 [No Abstract] [Full Text] [Related]
9. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis]. Chapurlat R; Meunier PJ Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126 [TBL] [Abstract][Full Text] [Related]
10. Further study of the therapy for fibrous dysplasia is necessary. Czerwiec FS; Collins M; Feuillan P; Shenker A J Bone Miner Res; 1997 Dec; 12(12):2128-30. PubMed ID: 9421248 [No Abstract] [Full Text] [Related]
11. [Fibrous dysplasia: overview]. Akasbi N; Abourazzak FE; Talbi S; Tahiri L; Harzy T Pan Afr Med J; 2015; 21():21. PubMed ID: 26401215 [TBL] [Abstract][Full Text] [Related]
12. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352 [TBL] [Abstract][Full Text] [Related]
15. Estimation of bone strength parameters and response to treatment using peripheral quantitative computed tomography. Blake GM J Clin Densitom; 2012; 15(4):385-386. PubMed ID: 22921770 [No Abstract] [Full Text] [Related]
16. Intravenous Bisphosphonate Therapy as a Rescue Analgesic in Refractory Fibrous Dysplasia. Hatcher L; Henry N; Hooten WM; D'Souza RS Pain Med; 2022 Dec; 23(12):2085-2089. PubMed ID: 35652736 [No Abstract] [Full Text] [Related]
17. Response letter to the article: recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia: a novel molecular mechanism. Namazi H Indian J Pediatr; 2012 Nov; 79(11):1535; author reply 1535-6. PubMed ID: 22231769 [No Abstract] [Full Text] [Related]
18. Estimation of bone strength parameters and response to treatment in McCune-Albright syndrome using peripheral quantitative computed tomography of the tibia. Atsali E; Zoubos AB; Stathopoulos KD; Stefos E; Bournazos I; Papadimitriou A; Nicolaidou P; Skarantavos G J Clin Densitom; 2012; 15(4):461-466. PubMed ID: 22819140 [No Abstract] [Full Text] [Related]
19. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone. Rotman M; Hamdy NAT; Appelman-Dijkstra NM Br J Clin Pharmacol; 2019 Jun; 85(6):1169-1179. PubMed ID: 30471134 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review. Mansoori LS; Catel CP; Rothman MS Endocr Pract; 2010; 16(5):851-4. PubMed ID: 20570808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]